These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 39399504)
1. Role of disulfidptosis in colorectal adenocarcinoma: implications for prognosis and immunity. Yang R; Lai C; Huang L; Li F; Peng W; Wu M; Xin J; Lu Y; Ouyang M; Bai Y; Lei H; He S; Lin Y Front Immunol; 2024; 15():1409149. PubMed ID: 39399504 [TBL] [Abstract][Full Text] [Related]
2. A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma. Hu G; Yao H; Wei Z; Li L; Yu Z; Li J; Luo X; Guo Z Sci Rep; 2023 Jul; 13(1):12403. PubMed ID: 37524774 [TBL] [Abstract][Full Text] [Related]
3. Identifying and evaluating a disulfidptosis-related gene signature to predict prognosis in colorectal adenocarcinoma patients. Li M; Wang J; Zhao Y; Lin C; Miao J; Ma X; Ye Z; Chen C; Tao K; Zhu P; Hu Q; Sun J; Gu J; Wei S Front Immunol; 2024; 15():1344637. PubMed ID: 38962013 [TBL] [Abstract][Full Text] [Related]
4. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients. Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324 [TBL] [Abstract][Full Text] [Related]
5. A disulfidptosis-related classification and risk signature identifies immunotherapy biomarkers and predicts prognosis in gastric cancer: An observational study. Chen R; Jiang L Medicine (Baltimore); 2024 May; 103(22):e38398. PubMed ID: 39259065 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer. Xiong Y; Kong X; Mei H; Wang J; Zhou S Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783 [TBL] [Abstract][Full Text] [Related]
7. Disulfidptosis-related lncRNAs signature predicting prognosis and immunotherapy effect in lung adenocarcinoma. Hong S; Zhang Y; Wang D; Wang H; Zhang H; Jiang J; Chen L Aging (Albany NY); 2024 Jun; 16(11):9972-9989. PubMed ID: 38862217 [TBL] [Abstract][Full Text] [Related]
8. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which Xu K; Zhang Y; Yan Z; Wang Y; Li Y; Qiu Q; Du Y; Chen Z; Liu X Front Immunol; 2023; 14():1205250. PubMed ID: 37426643 [TBL] [Abstract][Full Text] [Related]
9. Disulfidptosis-related genes serve as potential prognostic biomarkers and indicate tumor microenvironment characteristics and immunotherapy response in prostate cancer. Zhou R; Lu D; Mi J; Wang C; Lu W; Wang Z; Li X; Wei C; Zhang H; Ji J; Zhang Y; Zhang D; Wang F Sci Rep; 2024 Jun; 14(1):14107. PubMed ID: 38898043 [TBL] [Abstract][Full Text] [Related]
10. Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms. Chi H; Huang J; Yan Y; Jiang C; Zhang S; Chen H; Jiang L; Zhang J; Zhang Q; Yang G; Tian G Front Mol Biosci; 2023; 10():1254232. PubMed ID: 37916187 [No Abstract] [Full Text] [Related]
11. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction. Wang Z; Niu D Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070 [TBL] [Abstract][Full Text] [Related]
12. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients. Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348 [TBL] [Abstract][Full Text] [Related]
13. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma. Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J Aging (Albany NY); 2024 Jun; 16(11):9753-9783. PubMed ID: 38836761 [TBL] [Abstract][Full Text] [Related]
14. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms. Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936 [TBL] [Abstract][Full Text] [Related]
15. Construction of a Novel Disulfidptosis-Related lncRNA Prognostic Signature in Pancreatic Cancer. Xing F; Qin Y; Xu J; Wang W; Zhang B Mol Biotechnol; 2024 Sep; 66(9):2396-2414. PubMed ID: 37733182 [TBL] [Abstract][Full Text] [Related]
16. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma. Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203 [No Abstract] [Full Text] [Related]
17. Comprehensive analysis of bulk and single-cell RNA sequencing data reveals Schlafen-5 (SLFN5) as a novel prognosis and immunity. Wu YJ; Chiao CC; Chuang PK; Hsieh CB; Ko CY; Ko CC; Chang CF; Chen TY; Nguyen NUN; Hsu CC; Chu TH; Fang CC; Tsai HY; Tsai HC; Anuraga G; Ta HDK; Xuan DTM; Kumar S; Dey S; Wulandari FS; Manalu RT; Ly NP; Wang CY; Lee YK Int J Med Sci; 2024; 21(12):2348-2364. PubMed ID: 39310264 [TBL] [Abstract][Full Text] [Related]
18. Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis. Zhao F; Su L; Wang X; Luan J; Zhang X; Li Y; Li S; Hu L Clin Epigenetics; 2024 Feb; 16(1):26. PubMed ID: 38342890 [TBL] [Abstract][Full Text] [Related]
19. Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma. Cui G; Liu J; Wang M; Shon K; Wang C; Wei F; Sun Z Front Immunol; 2022; 13():1049485. PubMed ID: 36505481 [TBL] [Abstract][Full Text] [Related]
20. Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma. Liu J; Li H; Zhang N; Dong Q; Liang Z Curr Med Chem; 2024; 31(25):4034-4055. PubMed ID: 38685772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]